OptimizeRx (OPRX) vs Veeva Systems (VEEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Veeva Systems (VEEV) has outperformed OptimizeRx (OPRX) over the past year, losing 5.6% versus a loss of 54.1%. Over five years, VEEV leads with a -7.9% price change compared with -90.1% for OPRX. Veeva Systems is the larger company by market cap ($46.56 billion vs $159.4 million), about 292.2 times the size.
On valuation, OptimizeRx trades at a lower forward P/E (8.1x vs 28.1x for Veeva Systems).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OPRX | VEEV |
|---|---|---|
| Share price | $8.46 | $287.58 |
| Market cap | $159.35M | $46.56B |
| 1-day change | +0.95% | +0.96% |
| YTD return | -31.65% | +27.60% |
| 1-year return | -54.06% | -5.62% |
| 5-year return | -90.10% | -7.95% |
| P/E ratio (TTM) | 35.25 | 47.14 |
| Forward P/E | 8.10 | 28.05 |
| EPS (TTM) | $0.24 | $6.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $3.20B |
| Revenue growth (YoY) | — | +16.34% |
| Net income (latest FY) | — | $908.91M |
| Gross margin | — | 75.53% |
| Operating margin | — | 28.68% |
| Net margin | — | 28.44% |
| 52-week high | $22.25 | $302.17 |
| 52-week low | $4.54 | $148.05 |
| Distance from 52-week high | -61.98% | -4.83% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +48.93% | +2.67% |
| Average volume | 203.38K | 1.66M |
| Shares outstanding | 18.84M | 161.91M |
| Employees | 132 | 7,928 |
| Sector | Consumer Discretionary | Technology |
| Industry | Business Services | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Veeva Systems is about 292.2 times larger than OptimizeRx by market value ($46.56B vs $159.35M).
- VEEV has outperformed OPRX by 48.4 percentage points over the past year.
- Veeva Systems trades at a higher earnings multiple (47.1x vs 35.3x trailing P/E).
- The two companies sit in different sectors: OptimizeRx in Consumer Discretionary and Veeva Systems in Technology.
About OptimizeRx
OPRX stock →OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
Consumer Discretionary · Business Services · 132 employees
About Veeva Systems
VEEV stock →Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Technology · Computer Software: Prepackaged Software · 7,928 employees
OPRX vs VEEV FAQ
Which is bigger, OptimizeRx or Veeva Systems?
Veeva Systems (VEEV) is larger, with a market capitalization of $46.56B compared with $159.35M for OptimizeRx (OPRX).
Which stock has performed better over the past year, OPRX or VEEV?
VEEV returned -5.62% over the past 12 months, compared with -54.06% for OPRX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, OPRX or VEEV?
OPRX has the lower trailing P/E at 35.3, versus 47.1 for VEEV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are OptimizeRx and Veeva Systems in the same industry?
No. OptimizeRx is in the Consumer Discretionary sector, while Veeva Systems is in Technology.